Loss of myostatin attenuates severity of muscular dystrophy in mdx mice
- 4 November 2002
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 52 (6), 832-836
- https://doi.org/10.1002/ana.10385
Abstract
Myostatin, a transforming growth factor–β family member, is a negative regulator of skeletal muscle growth. To explore the therapeutic potential of targeting myostatin in settings of muscle degeneration, we crossed myostatin null mutant mice with mdx mice, a model for Duchenne and Becker muscular dystrophy. Mdx mice lacking myostatin were stronger and more muscular than their mdx counterparts. Diaphragm muscle showed less fibrosis and fatty remodeling, suggesting improved muscle regeneration.This publication has 13 references indexed in Scilit:
- Induction of Cachexia in Mice by Systemically Administered MyostatinScience, 2002
- Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin α2-deficient miceNeuromuscular Disorders, 2001
- Regulation of skeletal muscle mass in mice by a new TGF-p superfamily memberNature, 1997
- The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophyNature, 1991
- The Molecular Basis of Muscular Dystrophy in the mdx Mouse: a Point MutationScience, 1989
- THE mdx MOUSE SKELETAL MUSCLE MYOPATHY: I. A HISTOLOGICAL, MORPHOMETRIC AND BIOCHEMICAL INVESTIGATIONNeuropathology and Applied Neurobiology, 1988
- Muscular dystrophy in the mdx mouse: Histopathology of the soleus and extensor digitorum longus musclesJournal of the Neurological Sciences, 1987
- THE MUTANT mdx: INHERITED MYOPATHY IN THE MOUSEBrain, 1987
- Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouseActa Neuropathologica, 1986
- The histographic analysis of human muscle biopsies with regard to fiber typesNeurology, 1969